JCR Pharmaceuticals Co., Ltd.

4552.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income-¥5¥6¥5¥19
Dep. & Amort.¥3¥3¥2¥2
Deferred Tax¥0¥0-¥9-¥3
Stock-Based Comp.¥0¥0¥0¥0
Change in WC-¥0-¥6-¥3-¥9
Other Non-Cash-¥4¥7-¥1-¥0
Operating Cash Flow-¥5¥9-¥6¥9
Investing Activities
PP&E Inv.-¥10-¥2-¥9-¥11
Net Acquisitions¥0-¥1-¥7¥8
Inv. Purchases¥0¥0-¥1-¥0
Inv. Sales/Matur.¥0¥0¥0¥0
Other Inv. Act.-¥0¥0¥1-¥0
Investing Cash Flow-¥10-¥3-¥15-¥3
Financing Activities
Debt Repay.¥15¥1¥5-¥0
Stock Issued¥0¥0¥0¥0
Stock Repurch.-¥3¥0¥0¥0
Dividends Paid-¥3-¥3-¥3-¥2
Other Fin. Act.-¥0-¥0-¥0¥0
Financing Cash Flow¥10-¥2¥2-¥2
Forex Effect¥0¥1¥1¥1
Net Chg. in Cash-¥6¥5-¥17¥4
Supplemental Information
Beg. Cash¥19¥13¥31¥26
End Cash¥13¥19¥13¥31
Free Cash Flow-¥15¥7-¥14-¥2
JCR Pharmaceuticals Co., Ltd. (4552.T) Financial Statements & Key Stats | AlphaPilot